Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate

Prostate

Volumn 69, Issue 13, 2009, Pages 1378-1386

  Wang, Wanzhong ^a   Bergh, Anders ^b   Damber, Jan Erik ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Inflammation; PIN; Precursor; Proliferative inflammatory atrophy; Prostate cancer

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYTOKERATIN 5; EOSIN; GLUTATHIONE TRANSFERASE P1; HEMATOXYLIN; KI 67 ANTIGEN; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CHRONIC INFLAMMATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROLIFERATIVE INFLAMMATORY ATROPHY IN PROSTATE; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; STAINING;

ADENOCARCINOMA; ATROPHY; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; KI-67 ANTIGEN; MALE; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 69449093704     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20992     Document Type: Article

References (30)

1. Montironi R, Mazzucchelli R, Scarpelli M. Precancerous lesions and conditions of the prostate: From morphological and biological characterization to chemoprevention. Ann NY Acad Sci 2002;963:169-184. (Pubitemid 34721709)
2. Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: Evidence for a link? Eur Urol 2007;52(4):964-972.
3. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999;155(6):1985-1992.
4. De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB, Nelson WG. Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 2004;91(3):459-477.
5. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 2000;56(5):828-832.
6. Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, De Marzo AM. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: A detailed study using laser-capture microdissection. Am J Pathol 2003;163(3):923-933. (Pubitemid 37040128)
7. Ruska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 1998;22(9):1073-1077. (Pubitemid 28411064)
8. Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Postatrophic hyperplasia of the prostate gland: Neoplastic precursor or innocent bystander? Am J Pathol 2001;158(5):1767-1773.
9. Wang W, Bergh A, Damber JE. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate 2004;61(1):60-72.
10. van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, Schalken JA, De Marzo AM. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 2003;162(5):1529-1537.
11. Wang W, Bergh A, Damber JE. Increased expression of CCAAT/enhancer- binding protein beta in proliferative inflammatory atrophy of the prostate: Relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. Prostate 2007;67(11):1238-1246. (Pubitemid 47221891)
12. Macoska JA, Trybus TM, Wojno KJ. 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology 2000;55(5):776-782.
13. Tsujimoto Y, Takayama H, Nonomura N, Okuyama A, Aozasa K. Postatrophic hyperplasia of the prostate in Japan: Histologic and immunohistochemical features and p53 gene mutation analysis. Prostate 2002;52(4):279-287. (Pubitemid 34898894)
14. Franks LM. Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol 1954;68(2):617-621.
15. Liavag I. The localization of prostatic carcinoma. An autopsy study. Scand J Urol Nephrol 1968;2(2):65-71.
16. Nakai Y, Nelson WG, De Marzo AM. The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 2007;67(3):1378-1384.
17. Billis A. Prostatic atrophy: An autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 1998;11(1):47-54. (Pubitemid 28177363)
18. Billis A, Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 2003;127(7):840-844.
19. Postma R, Schroder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 2005;65(4):745-749. (Pubitemid 40523011)
20. Anton RC, Kattan MW, Chakraborty S, Wheeler TM. Postatrophic hyperplasia of the prostate: Lack of association with prostate cancer. Am J Surg Pathol 1999;23(8):932-936. (Pubitemid 29360111)
21. Gardner WA Jr, Culberson DE. Atrophy and proliferation in the young adult prostate. J Urol 1987;137(1):53-56.
22. Tomas D, Kruslin B, Rogatsch H, Schafer G, Belicza M, Mikuz G. Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol 2007;51(1):98-103. discussion 03-4. (Pubitemid 44821517)
23. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report. Scand J Urol Nephrol Suppl 2000; (205):3-10. (Pubitemid 32056461)
24. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24(3):298-310. (Pubitemid 23086366)
25. Vis AN, van der Kwast TH. Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: A clinical perspective. BJU Int 2001;88(2):147-157. (Pubitemid 34203402)
26. Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R, Sakr WA. Cellular and molecular pathology of prostate cancer precursors. Scand J Urol Nephrol Suppl 2000;(205):19-43. (Pubitemid 32056463)
27. Qian J, Bostwick DG. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract 1995;191(9):860-867.
28. Goeman L, Joniau S, Ponette D, Van der Aa F, Roskams T, Oyen R, Van Poppel H. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? Prostate Cancer Prostatic Dis 2003;6(4):305-310.
29. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M. Mechanisms of disease: High-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol 2007;4(6):321-332. (Pubitemid 46901993)
30. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65(23):10946-10951. (Pubitemid 41713363)